Epirus Biopharmaceuticals Inc Share Price Nasdaq
Equities
US29428P1075
Biotechnology & Medical Research
Sales 2014 | 0 0.33 | Sales 2015 | 0.7 58.37 | Capitalization | 75.33M 6.27B |
---|---|---|---|---|---|
Net income 2014 | -41M -3.41B | Net income 2015 | -52M -4.33B | EV / Sales 2014 | 14,77,02,94,750 x |
Net cash position 2014 | 14.18M 1.18B | Net cash position 2015 | 16.68M 1.39B | EV / Sales 2015 | 8,36,58,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |